Clinical trial in Seattle aims to transform treatment approaches for pediatric IBD

FHS
May 14, 2024
1:37 pm

With pediatric inflammatory bowel disease (IBD) diagnoses on the rise globally, a clinical trial in Seattle aims to transform treatment approaches through deep molecular profiling.

Canadian LP Bargains

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

September 19, 2024

Risk Adjusted Net Present Value: What is the current valuation of PMV Pharmaceuticals’s Rezatapopt

The revenue for Rezatapopt is expected to reach an annual total of $63 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

InComm Payments Acquires AI-Powered HSA Solution Zenda

What You Should Know: InComm Payments announced it has acquired Zenda, an AI-powered HSA and FSA solution. With aligned organizational goals of “helping more people

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.